Possible use of fondaparinux in heparin-induced thrombocytopenia

Int J Cardiol. 2018 Apr 1:256:3. doi: 10.1016/j.ijcard.2017.12.029.

Authors

Kumar Ashish¹, Dhrubajyoti Bandyopadhyay², Adrija Hajra³, Raktim K Ghosh⁴

Affiliations

¹ University of Texas MD Anderson Cancer Center, USA.
² Mount Sinai St Luke's Roosevelt, New York, NY, USA. Electronic address: [email protected].
³ IPGMER, India.
⁴ MetroHealth, Case Western Reserve University, Cleveland, OH, USA.

PMID: 29454410
DOI: 10.1016/j.ijcard.2017.12.029

No abstract available

Keywords: Direct thrombin inhibitors (DTI); Fondaparinux; Heparin-induced thrombocytopenia.

Publication types

Letter
Comment

MeSH terms

Anticoagulants
Fondaparinux
Heparin
Polysaccharides*
Thrombocytopenia*

Substances

Anticoagulants
Polysaccharides
Heparin
Fondaparinux